A Novel Treatment Modality for Malignant Peripheral Nerve Sheath Tumor Using a Dual-Effect Liposome to Combine Photodynamic Therapy and Chemotherapy
Neurofibromatosis type 1 (NF1) is an inherited neurological disorder. Approximately 5–13% of NF1 patients may develop a malignant peripheral nerve sheath tumor (MPNST), which is a neurofibrosarcoma transformed from the plexiform neurofibroma or schwannoma. Given the large size and easy metastasis of...
Main Authors: | Chin-Tin Chen, Po-Chun Peng, Tsuimin Tsai, Hsiung-Fei Chien, Ming-Jen Lee |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-04-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/12/4/317 |
Similar Items
-
Retroperitoneal Malignant Peripheral Nerve Sheath Tumour: A Rare Case Report
by: Ayse Nur Deger, et al.
Published: (2015-09-01) -
Superficial malignant peripheral nerve sheath tumor from recurrent neurofibroma in the abdominal wall of a patient without neurofibromatosis type 1
by: Chang Yeon Jung, et al.
Published: (2019-01-01) -
Retroperitoneal Neurofibroma and a Malignant Peripheral Nerve Sheath Tumor with Neurofibromatosis Type 1: A Report of Two Cases
by: Kumiko Yotsuya, et al.
Published: (2020-10-01) -
From Genes to -Omics: The Evolving Molecular Landscape of Malignant Peripheral Nerve Sheath Tumor
by: Kathryn M. Lemberg, et al.
Published: (2020-06-01) -
Peripheral nerve sheath tumors of the upper extremity and hand in patients with neurofibromatosis type 1: topography of tumors and evaluation of surgical treatment in 62 patients
by: Friedrich, Reinhard E., et al.
Published: (2017-12-01)